SB 494 – Rhode IslandStatus: Inactive / Dead
Year Introduced: 2021
AN ACT RELATING TO INSURANCE: Requires drug companies disclose to office of the health insurance commissioner acquisition costs of drugs approved by FDA, if acquisition cost is at least $100 for 30 day supply and requires disclosure of rebates, price protection payments.
Return to Database Search
© 2018- The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.